Method and apparatus for prevention of arrhythmia clusters using overdrive pacing
First Claim
Patent Images
1. An implantable medical device, comprising:
- a microprocessor characterizing cardiac activity of a patient, the implantable medical device delivering therapy in response to an identified arrhythmia event; and
a monitor/controller monitoring the characterized cardiac activity and the delivered therapy, and controlling activation of triggered overdrive pacing subsequent to the delivered therapy.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable medical device that includes a microprocessor that characterizes cardiac activity of a patient to enable the implantable medical device to deliver therapy in response to an identified arrhythmia event. A monitor/controller monitors the characterized cardiac activity and the delivered therapy, and controls activation of triggered overdrive pacing subsequent to the delivered therapy.
-
Citations
36 Claims
-
1. An implantable medical device, comprising:
-
a microprocessor characterizing cardiac activity of a patient, the implantable medical device delivering therapy in response to an identified arrhythmia event; and
a monitor/controller monitoring the characterized cardiac activity and the delivered therapy, and controlling activation of triggered overdrive pacing subsequent to the delivered therapy. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. A method for detecting arrhythmias in an implantable medical device, comprising the steps of:
-
determining whether an arrhythmia event has terminated in response to a delivered therapy;
determining whether triggered overdrive pacing is active;
determining whether to terminate triggered overdrive pacing in response to triggered overdrive pacing being active;
determining whether the arrhythmia event is associated with an arrhythmia cluster in response to triggered overdrive pacing not being active;
determining whether triggered overdrive pacing is appropriate; and
delivering triggered overdrive pacing in response to the arrhythmia event being associated with an arrhythmia cluster and triggered overdrive pacing being appropriate. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
-
-
29. An implantable medical device, comprising:
-
a microprocessor characterizing cardiac activity of a patient, the implantable medical device delivering therapy in response to an identified arrhythmia event;
a monitor/controller monitoring the characterized cardiac activity and the delivered therapy, and controlling activation of triggered overdrive pacing subsequent to the delivered therapy, the monitor/controller determining, prior to activation of triggered overdrive pacing, one or more of a triggered overdrive pacing rate, a triggered overdrive pacing duration, and a step down period;
an ischemia detector detecting whether ischemia is present in the patient; and
a hemodynamics detector detecting hemodynamics of the patient, wherein the monitor/controller determines whether an arrhythmia event has terminated in response to the delivered therapy, determines whether to terminate triggered overdrive pacing in response to triggered overdrive pacing being active, determines whether the arrhythmia event is associated with an arrhythmia cluster in response to triggered overdrive pacing not being active, and activates triggered overdrive pacing in response to the arrhythmia event being associated with an arrhythmia cluster and triggered overdrive pacing being appropriate, wherein the monitor/controller determines that triggered overdrive pacing is appropriate in response to a heart rate of the patient being less than a first predetermined threshold and ischemia not being present, and wherein, prior to activating the triggered overdrive pacing, the triggered overdrive pacing rate is dynamically adjusted by the monitor/controller based on one of a percentage of a patient'"'"'s heart rate, prior success of triggered overdrive pacing, and the detected hemodynamics of the patient, the triggered overdrive pacing duration is determined as being one of a predetermined time period, automatically adjusted based on prior triggered overdrive pacing, automatically adjusted based on events during or subsequent to the step down period, and a percentage of inter-detection intervals between detected arrhythmia events, and the step down period is calculated as a fraction of a time duration for performing triggered overdrive pacing. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36)
-
Specification